LUPUS ABC

The Lupus Accelerating Breakthroughs Consortium (Lupus ABC) is the first public-private partnership with the U.S. Food and Drug Administration (FDA) that focuses specifically on advancing the development of safer and more effective treatments urgently needed for people with lupus. In collaboration with key stakeholders, Lupus ABC is bringing together people with lupus, federal agencies, medical societies, advocacy groups, industry, academic clinical researchers, and scientists, with the FDA, to overcome the scientific hurdles in drug development that are beyond the capacity of any single entity... Lupus Accelerating Breakthroughs Consortium was founded in 2023, spearheaded by the Lupus Research Alliance in collaboration with the U.S. Food and Drug Administration and the lupus community